Variability in DNA distributions of human neuroblastomas after cyclophosphamide

Y. L. Danon, M. B. Epstein, M. M. Siegel, N. Rucker, C. P. Myers, A. Norman, W. F. Benedict, R. C. Seeger

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Major changes in DNA distributions of two human neuroblastoma cell lines growing in vitro and in athymic nude mice occurred after treatment with cyclophosphamide. Pulse treatment of LA-N-1 cells in vitro with liver S-9-activated cyclophosphamide (10 μg/ml) caused approximately 50% cytotoxicity; flow microfluorometric analysis of surviving cells demonstrated an increased proportion of G 2 + M cells and a decreased proportion of G 1 cells, particularly at 48 hrs. Even though LA-N-1 tumors in nude mice did not regress after one dose of cyclophosphamide (250 mg/kg), the percent of G 2 + M cells increased and the percent of G 1 cells decreased 4-6 days after treatment; the percent of cells in S increased at 2 and again at 8 days. SK-N-MC cells were affected differently by cyclophosphamide. Pulse treatment of these cells in vitro with liver S-9-activated cyclophosphamide caused > 85% cytotoxicity and nearly complete elimination of cells in G 2 + M at 24 and 48 hrs. Likewise, SK-N-MC tumors in nude mice regressed > 50% after cyclophosphamide, and the proportion of G 2 + M cells decreased markedly 2-6 days after therapy. We conclude that cyclophosphamide can have different cytotoxic and cytokinetic effects on neuroblastomas. In addition, marked cytokinetic effects may occur even though changes in tumor size are minimal or not detectable.

Original languageEnglish (US)
Pages (from-to)1275-1281
Number of pages7
JournalCancer Treatment Reports
Volume64
Issue number12
StatePublished - 1980

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Variability in DNA distributions of human neuroblastomas after cyclophosphamide'. Together they form a unique fingerprint.

Cite this